A novel, lab-made molecule was able to stick to certain inflammatory proteins and decrease and minimize acute breathing issues among people with moderate-to-severe asthma, according to new research by the University of Pittsburgh School of Medicine. The findings were published in the New England Journal of Medicine, and were also presented in Philadelphia at the annual meeting of the American Thoracic Society. Nearly 24.6 million Americans suffer from asthma, and 10 to 20% of them do not have good control of their symptoms even when taking medications...
More...
More...